Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) in the framework of the Council Decision on new psychoactive substances

Series type: Risk assessments

Summary

This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 23 May 2017. On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 15 November 2017, the Council decided that furanylfentanyl should be subject to control measures across the Member States.

Download as PDF

Table of contents

  • Foreword
  • EMCDDA actions on monitoring and responding to new drugs
  • EMCDDA–Europol Joint Report on furanylfentanyl: a summary
  • Risk Assessment Report of a new psychoactive substance: furanylfentanyl
  • Annex 1: Technical report on furanylfentanyl
  • Council Decision on subjecting furanylfentanyl to control measures
  • Participants of the risk assessment meeting
Pages: 
49
Price: 
Free
ISBN: 
978-92-9497-244-6
ISSN: 
1725-4493
Pub. DOI: 
10.2810/22200
Catalog Number: 
TD-AK-17-002-EN-C
Loading